Join to View Full Profile
9500 Euclid AveCleveland, OH 44195
Phone+1 216-444-2200
Dr. Almassi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Nima Almassi is a Urologic Oncologist at Cleveland Clinic. He obtained his medical degree from the Medical College of Wisconsin, completed urology residency training at Cleveland Clinic, and pursued fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center. He specializes in management of bladder, prostate, kidney, and penile cancer. His research interests includes bladder-sparing treatment in very high risk non-muscle invasive bladder cancer with variant histology, predictive biomarkers of treatment response to multimodal treatment of bladder cancer, the impact of body composition and sarcopenia on treatment outcomes in patients with urologic malignancy, and innovations in surgical treatment of urologic cancers.
Education & Training
Cleveland Clinic FoundationResidency, Urology, 2012 - 2018
Medical College of WisconsinClass of 2012
Certifications & Licensure
OH State Medical License 2020 - 2026
NY State Medical License 2017 - 2021
American Board of Urology Urology
Publications & Presentations
PubMed
- Re-appraisal of Standard of Care Imaging to Identify Predictors of Treatment Outcomes among Patients with Bladder and Upper Tract Urothelial Cancers.Shelby Harper, Erick M Remer, Nima Almassi
Current Urology Reports. 2025-06-21 - Association between Midline Extraction Incision and Increased Risk of Incisional Hernia Following Minimally-invasive Radical Nephrectomy: Results of an Observational S...Zaeem Lone, Shelby Harper, David Shin, Erin Brooks, Erin Kim
The Journal of Urology. 2025-06-18 - A Split Renal Function-Based Approach for Predicting New Baseline Glomerular Filtration Rate After Radical Nephroureterectomy.Kieran Lewis, Jayant Siva, Angelica Bartholomew, Anne Wong, Carlos Munoz Lopez
Urology Practice. 2025-05-05
Press Mentions
BCG Response in Bladder Cancer Cases Linked to Tumor MicrobiomeMay 16th, 2023- Gopa Iyer, MD, on Glandular-Phenotype Bladder CancerOctober 27th, 2022
- Clinical Challenge: Urinary Diversion Methods in Bladder CancerDecember 6th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
